| Literature DB >> 26166861 |
Jarosław Sławiński1, Beata Żołnowska1, Czesława Orlewska1, Jarosław Chojnacki2.
Abstract
ABSTRACT: A series of novel 4-chloro-N-(4,5-dihydro-5-oxo-1-R2-1H-1,2,4-triazol-3-yl)-5-methyl-2-(R1-methylthio)benzenesulfonamide derivatives have been synthesized as potential anticancer agents. The in vitro antitumor activity of some compounds was evaluated in the US National Cancer Institute (NCI) against the NCI-60 cell line panel. The most prominent compound showed remarkable activity against 13 human tumor cell lines representing lung, colon, CNS, melanoma, ovarian, renal, prostate, and breast at low micromolar GI50 level in the range of 1.9-3.0 μM.Entities:
Keywords: Anticancer; Cyclization; Isocyanate; Sulfonamide; Triazolone
Year: 2012 PMID: 26166861 PMCID: PMC4495025 DOI: 10.1007/s00706-012-0849-7
Source DB: PubMed Journal: Monatsh Chem ISSN: 0026-9247 Impact factor: 1.451